Neurologic Emergencies Stroke & Tia: Devin R. Harris, MD MHSC CCFP (Em)
Neurologic Emergencies Stroke & Tia: Devin R. Harris, MD MHSC CCFP (Em)
Neurologic Emergencies Stroke & Tia: Devin R. Harris, MD MHSC CCFP (Em)
Neurologic Emergencies
Stroke is the fourth leading cause of death in Canada and is the leading cause of
disability. Each year, there are between 40,000 to 50,000 strokes and 16,000
people die from stroke in Canada. Currently, there are approximately 300,000
Canadians living with a disability from stroke.
A stroke results from any disease process that disrupts vascular blood flow to a
distinct region of the brain. It is caused by the interruption of the flow of blood to
the brain (an ischemic stroke) or the rupture of blood vessels in the brain (a
hemorrhagic stroke).
STROKE TYPES
Ischemic Stroke (80%)
Although hemorrhagic stroke comprise only one of every five strokes, they have
a mortality rate of 30 to 50% at one month and occur in younger patients.
CLINICAL FEATURES
History
Often, the etiology of the stroke can be predicted based on the patient’s
demographics and past medical history. Younger patients are more likely to
have a hemorrhagic stroke than older patients. Hypertension, coronary artery
disease and diabetes suggest an atherosclerotic cause for stroke. Atrial
fibrillation, valvular replacement or a recent myocardial infarction suggest an
embolic cause.
Physical Examination
General
Neurologic Examination
The goal of the neurologic examination is to localize the brain lesion (where is
the lesion, what is the lesion?) and to rule out other neurologic disease
processes. The neurologic examination can be divided into the following areas:
2. Cranial Nerves
3. Visual Assessment
Evaluate visual fields and extraocular movements
4. Language
Determination of dysarthria (disturbance in articulation due to
paralysis or incoordination of muscles used for speech) or aphasia
(disturbance in processing language).
Aphasia may be receptive (comprehension) or expressive
(communicating thoughts) or both
5. Sensory
Sensory deficits and neglect should be evaluated by pinprick
testing and double-simultaneous extinction (touch the patient’s right
and left limbs individually and then simultaneously)
6. Cerebellar Function
Finger-to-nose testing, heel-to-shin testing, rapid alternating
movements can be tested.
If the patient can stand, perform a Romberg test
7. Gait
Not always possible to perform in the stroke patient
Stroke Syndromes
4. Vertebrobasilar syndrome
The posterior circulation supplies blood to the brainstem, cerebellum
and visual cortex
Findings may include dizziness, vertigo, diplopia, dysphagia, ataxia,
cranial nerve palsies, and limb weakness
Hallmark is “crossed neurologic deficits” (ipsilateral cranial nerve
deficits with contralateral motor weakness)
6. Cerebellar infarct
Patients may present with a “drop attack” – sudden inability to walk or
stand
Findings include vertigo, headache, nausea, vomiting and neck pain
At risk of developing significant edema and increased brainstem
pressure
7. Lacunar infarcts
Pure motor or pure sensory deficits that are due to infarction of small
penetrating arteries
Commonly associated with chronic hypertension
8. Arterial dissection
May be associated with trauma or neck injury
May occur in the carotid (anterior) and vertebral (posterior) circulation
1. Intracerebral hemorrhage
May be clinically indistinguishable from cerebral infarction (above
syndromes)
More commonly lethargic and may have significant hypertension
Often associated with headache, nausea and vomiting
Bleeding often localized to (in order of frequency): putamen, thalamus,
pons, or cerebellum
2. Subarachnoid hemorrhage
Sudden onset of severe constant headache (worst headache of their
life) that is often occipital or nuchal; often with straining
May have had a “sentinel hemorrhage” – a severe headache lasting for
a few days prior to the event that brought them to the emergency
department
Vomiting common; may have decreased level of consciousness
Differential Diagnosis
Most common:
Postictal paralysis (Todd’s paralysis)
Systemic infections
Tumours
Toxic-metabolic disturbances (hypoglycaemia, diabetic ketoacidosis,
hyperosmotic coma, Wernicke’s encephalopathy)
Other causes:
Bell’s palsy, epidural/subdural hematoma, complicated migraine,
labyrinthitis, Meniere’s disease, drug toxicity
Diagnostic Tests
All patients with suspected stroke should undergo rapid laboratory testing and
imaging.
Laboratory Tests
CBC with platelet count – identifies polycythemia, thrombocytosis or
thrombocytopenia
INR, PTT – rule out coagulopathy or excessive anticoagulation with
warfarin
Glucose – should be determined early, ideally by paramedical personnel.
If hypoglycaemic, 50% dextrose should be administered immediately.
Electrocardiogram (ECG)
Atrial fibrillation and acute myocardial infarction are associated with up to
60% of all cardioembolic strokes
Lumbar puncture
Required in all patients in whom SAH is suspected but who have a normal
CT scan
Other tests
Depending on clinical scenario, patients may necessitate:
o Echocardiogram – mural thrombus, tumour, valvular vegetation
o Carotid duplex – to detect carotid stenosis
o Magnetic resonance imaging (MRI) – good to detect very early
ischemia; poor at differentiating ischemia from hemorrhage
o CT angiogram / MR angiogram – to detect intravascular occlusion
or sources of hemorrhage
Treatment – Ischemic Stroke
General Treatment
All patients with stroke symptoms should not receive any by mouth (NPO) until
their swallowing status has been assessed. They are at risk of aspiration.
If your hospital has a stroke team, the stroke team should be activated either pre-
hospital or when the patient arrives in the emergency department. Neurology
should be consulted on all acute (less than 3 hours) stroke patients.
Specific Treatments
1. Thrombolysis
Some evidence that stroke can be treated (reduce morbidity) if given
within 3 hours of neurologic deficit onset
Patients who present under 3 hours since onset of symptoms need
rapid assessment, rapid CT scanning and rapid administration of
thombolytics
Exclusions: minor or improving stroke symptoms; previous ICH;
seizure; low or high glucose; GI or GU bleeding within 21 days; recent
MI; major surgery within 14 days; blood pressure > 185 systolic or >
110 diastolic; previous stroke within 90 days; previous head injury
within 90 days; on oral anticoagulants (or INR > 1.7); platelet <
100,000; proliferative diabetic retinopathy
Dose: rt-PA 0.9 mg/kg; 10% given as a bolus with the remaining 90%
given over 60 minutes; maximum dose 90 mg.
CT scan should be interpreted by a neurologist or radiologist; rt-PA
should be given by a neurologist
All patients given rt-PA should be admitted to an intensive care unit or
a neurology intensive care unit for monitoring
2. Platelet inhibitors
After CT scan to rule out hemorrhage, all patients should be
considered for a platelet inhibitor acutely
Best evidence for acetylsalicylic acid (ASA) – no difference between
low dose (80 mg) vs. high dose (1000 mg)
Also can consider: Dipyridamole (200 mg) or clopidogrel (300 mg)
3. Anticoagulants
No evidence for anticoagulants (heparin or coumadin) to treat ischemic
thrombotic stroke
Excellent evident to treat patients who have atrial fibrillation and
presumed embolic stroke – timing of anticoagulation is controversial.
Consultation is necessary.
Also may be considered in recurrent TIA’s, high grade carotid artery
stenosis and vertebrobasilar infarction
Again, all patients should be evaluated with respect to their ABC’s and should be
resuscitated and stabilized.
Intracerebral Hemorrhage
Blood pressure should be maintained less than 220 / 120 as per published
recommendations. Use labetolol or nitroprusside.
Treat increased intracranial pressure with standard measures (mannitol,
furosemide; hyperventilation is controversial)
Urgent neurosurgical consultation – surgical intervention is warranted for
some cases
Subarachnoid Hemorrhage
Blood pressure should be maintained at “prehemorrhage levels” due to a
high risk of rebleeding – treat blood pressure aggressively
Vasospasm may occur 2 days to 3 weeks after aneurysm rupture –
prescribe nimodipine 60 mg PO QID for all patients
Urgent neurosurgical consultation
TRANSIENT ISCHEMIC ATTACK (TIA)
Patients who present after a TIA should be evaluated in the same manner
described above. Timing of the event and symptoms during the event (motor
weakness, speech difficulties, dizziness) should be determined; patients should
also be questioned if this is a recurrent event. A cardiovascular exam should be
performed, specifically to listen for carotid bruits and to assess heart rate (regular
vs. irregular). A complete neurological exam should be performed to determine if
the patient has residual deficits.
Investigations
Laboratory: CBC, electrolytes, glucose, INR, PTT
Electrocardiogram
CT scan
Carotid Doppler ultrasound – not necessarily needs to be performed in
the emergency department, but should be ordered
Echocardiogram – consider in patients who have a history of MI
Treatment
All patients should be prescribed an antiplatelet agent – aspirin is first-line.
If on aspirin, consider adding a second antiplatelet agent
Patients with atrial fibrillation and a TIA need to be anticoagulated
Blood pressure and lipid status should be determined at some point after
a TIA, but this does not need to be done in the emergency department
Disposition
Some centers admit all TIA patients for urgent evaluation
Consultation and admission should be considered for patients with atrial
fibrillation, recurrent TIA events, vertrobasilar symptoms, or significant
comorbidities.
If discharged (and available), should be referred to a stroke prevention
clinic or neurologist for follow up.